Ruxolinitib As Salvage Therapy for Chronic Graft-Versus-Host Disease

被引：0
作者：
Modi, Badri
Hernandez-Henderson, Michael
Kopp, Erin
Yang, Dongyun
Huelsman, Karen
Sollena, Pietro
Zain, Jasmine M.
Ali, Haris
Al Malki, Monzr M.
Spielberger, Ricardo
Dadwal, Sanjeet
Salhotra, Amandeep
Forman, Stephen J.
Parker, Pablo
Nakamura, Ryotaro
机构：
来源：
BLOOD | 2017年 / 130卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1976
引用
收藏
页数：2
相关论文
共 50 条
[41]   Rehabilitation in Chronic Graft-Versus-Host Disease [J].
Smith, Sean Robinson ;
Asher, Arash .
PHYSICAL MEDICINE AND REHABILITATION CLINICS OF NORTH AMERICA, 2017, 28 (01) :143-+
[42]   Chronic graft-versus-host disease and seizure [J].
Azuno, Y ;
Yaga, K ;
Kaneko, T ;
Kaku, K ;
Oka, Y .
BLOOD, 1998, 91 (07) :2626-2628
[43]   Dasatinib as Salvage Therapy for Steroid Refractory and Imatinib Resistant or Intolerant Sclerotic Chronic Graft-versus-Host Disease [J].
Sanchez-Ortega, Isabel ;
Servitje, Octavio ;
Arnan, Montserrat ;
Orti, Guillermo ;
Peralta, Teresa ;
Manresa, Federico ;
Duarte, Rafael F. .
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2012, 18 (02) :318-323
[44]   Ruxolitinib for Chronic Graft-versus-Host Disease [J].
Gratwohl, Alois .
NEW ENGLAND JOURNAL OF MEDICINE, 2021, 385 (17) :1631-1631
[45]   The pathophysiology of chronic graft-versus-host disease [J].
Kansu, E .
INTERNATIONAL JOURNAL OF HEMATOLOGY, 2004, 79 (03) :209-215
[46]   Management of Chronic Graft-Versus-Host Disease [J].
Baker, Melissa ;
McKiernan, Phyllis .
CLINICAL JOURNAL OF ONCOLOGY NURSING, 2011, 15 (04) :429-432
[47]   The pathophysiology of chronic graft-versus-host disease [J].
Emin Kansu .
International Journal of Hematology, 2004, 79 :209-215
[48]   THE BIOLOGY OF CHRONIC GRAFT-VERSUS-HOST DISEASE [J].
DEEG, HJ .
EXPERIMENTAL HEMATOLOGY, 1985, 13 :128-130
[49]   The Treatment of Chronic Graft-Versus-Host Disease [J].
Wolff, Daniel ;
Bertz, Hartmut ;
Greinix, Hildegard ;
Lawitschka, Anita ;
Halter, Joerg ;
Holler, Ernst .
DEUTSCHES ARZTEBLATT INTERNATIONAL, 2011, 108 (43) :732-I
[50]   NEUTROPENIA IS A COMPLICATION OF THALIDOMIDE THERAPY FOR CHRONIC GRAFT-VERSUS-HOST DISEASE [J].
PARKER, PM ;
NADEMANEE, A ;
ODONNELL, MR ;
SNYDER, DS ;
STEIN, A ;
SMITH, E ;
MOLINA, A ;
STEPAN, DE ;
CHAO, N ;
NILAND, JC ;
BLUME, KG ;
FORMAN, SJ .
BLOOD, 1994, 84 (10) :A335-A335
12345